Increased breast cancer cell toxicity by palladination of the polyamine analogue N1,N11-bis(ethyl)norspermine

Amino Acids

Volumn 46, Issue 2, 2014, Pages 339-352

  Silva, Tania M ^a,b,c   Fiuza, Sonia M ^a   Marques, Maria P M ^a,d   Persson, Lo ^c   Oredsson, Stina ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Breast cancer; Cancer stem cells; DNA damage; Palladium (Pd)(II) complexes; Platinum (Pt)(II) complexes; Polyamine analogues

Indexed keywords

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COORDINATION COMPLEXES; DNA DAMAGE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GLUTATHIONE; HUMANS; INHIBITORY CONCENTRATION 50; NEOPLASTIC STEM CELLS;

EID: 84895910981     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1621-y     Document Type: Conference Paper

References (44)

1. Al-Hajj M, Wicha, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988. doi: 10.1073/pnas.0530291100
2. Brabec V, Kasparkova J (2005) Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug resist updates: reviews and commentaries in antimicrobial and anticancer. Chemotherapy 8(3):131-146. doi: 10.1016/j.drup.2005.04.006
3. Casero RA Jr, Woster PM (2009) Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem 52(15):4551-4573. doi: 10.1021/jm900187v
4. Cervelli M, Bellavia G, Fratini E, Amendola R, Polticelli F, Barba M, Federico R, Signore F, Gucciardo G, Grillo R, Woster PM, Casero RA Jr, Mariottini P (2010) Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm. BMC Cancer 10:555. doi: 10.1186/1471-2407-10-555
5. Chen HH, Kuo MT (2010) Role of glutathione in the regulation of cisplatin resistance in cancer chemotherapy. Met Based Drugs. doi: 10.1155/2010/430939
6. Cirenajwis H, Smiljanic S, Honeth G, Hegardt C, Marton LJ, Oredsson SM (2010) Reduction of the putative CD44 + CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047. Anticancer Drugs 21(10):897-906. doi: 10.1097/CAD.0b013e32833f2f77
7. Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero RA Jr (1999) Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer 6(1):69-73
8. Esteban-Fernandez D, Moreno-Gordaliza E, Canas B, Palacios MA, Gomez-Gomez MM (2010) Analytical methodologies for metallomics studies of antitumor Pt-containing drugs. Metallomics Integr Biometal Sci 2(1):19-38. doi: 10.1039/b911438f
9. Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10(2):R25. doi: 10.1186/bcr1982
10. Fiuza SM, Amado AM, Oliveira PJ, Sardão VA, Batista De Carvalho LAE, Marques MPM (2006) Pt(II) vs Pd(II) polyamine complexes as new anticancer drugs: a structure-activity study. Lett Drug Des Discov 3(3):149-151
11. Fiuza SM, Holy J, Batista de Carvalho LA, Marques MP (2011) Biologic activity of a dinuclear Pd (II)-spermine complex toward human breast cancer. Chem Biol Drug Des 77(6):477-488. doi: 10.1111/j.1747-0285.2011.01081.x
12. Freiburghaus C, Lindmark-Mansson H, Paulsson M, Oredsson S (2012) Reduction of ultraviolet light-induced DNA damage in human colon cancer cells treated with a lactoferrin-derived peptide. J Dairy Sci 95(10):5552-5560. doi: 10.3168/jds.2011-5279
13. Hegardt C, Johannsson OT, Oredsson SM (2002) Rapid caspase-dependent cell death in cultured human breast cancer cells induced by the polyamine analogue N (1), N (11)-diethylnorspermine. Eur J Biochem/FEBS 269(3):1033-1039
14. Hegmans A, Kasparkova J, Vrana O, Kelland LR, Brabec V, Farrell NP (2008) Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity. J Med Chem 51(7):2254-2260. doi: 10.1021/jm070813z
15. Holst CM, Oredsson SM (2005) Comparison of three cytotoxicity tests in the evaluation of the cytotoxicity of a spermine analogue on human breast cancer cell lines. Toxicol In Vitro Int J Publ Assoc BIBRA 19(3):379-387. doi: 10.1016/j.tiv.2004.10.005
16. Iacomino G, Picariello G (1823) D'Agostino L (2012) DNA and nuclear aggregates of polyamines. Biochim Biophys Acta 10:1745-1755. doi: 10.1016/j.bbamcr.2012.05.033
17. Johannsson OT, Staff S, Vallon-Christersson J, Kytola S, Gudjonsson T, Rennstam K, Hedenfalk IA, Adeyinka A, Kjellen E, Wennerberg J, Baldetorp B, Petersen OW, Olsson H, Oredsson S, Isola J, Borg A (2003) Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab Invest A J Tech Methods Pathol 83(3):387-396
18. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4(7):e6146. doi: 10.1371/journal.pone.0006146
19. Kim J, Villadsen R, Sorlie T, Fogh L, Gronlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H, Edwards PA, Borresen-Dale AL, Ronnov-Jessen L, Bissell MJ, Petersen OW (2012) Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci USA 109(16):6124-6129. doi: 10.1073/pnas.1203203109
20. Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34(10):1522-1534
21. Lim MC (1977) Mixed-ligand complexes of palladium(Ii).1. diaqua(ethylenediamine)palladium(Ii) complexes of glycylglycine and glycinamide. J Chem Soc Dalton 1:15-17. doi: 10.1039/Dt9770000015
22. Marques MP, Girao T, De Pedroso Lima MC, Gameiro A, Pereira E, Garcia P (2002) Cytotoxic effects of metal complexes of biogenic polyamines. I. Platinum(II) spermidine compounds: prediction of their antitumour activity. Biochim Biophys Acta 1589(1):63-70
23. Matsui I, Wiegand L, Pegg AE (1981) Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J Biol Chem 256(5):2454-2459
24. McCloskey DE, Woster PM, Casero RA Jr, Davidson NE (2000) Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells. Clin Cancer Res 6(1):17-23
25. Miklasova N, Fischer-Fodor E, Lonnecke P, Tomuleasa CI, Virag P, Schrepler MP, Miklas R, Dumitrescu LS, Hey-Hawkins E (2012) Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro. Eur J Med Chem 49:41-47. doi: 10.1016/j.ejmech.2011.12.001
26. Oredsson SM, Alm K, Dahlberg E, Holst CM, Johansson VM, Myhre L, Soderstjerna E (2007) Inhibition of cell proliferation and induction of apoptosis by N(1), N(11)-diethylnorspermine-induced polyamine pool reduction. Biochem Soc Trans 35(Pt 2):405-409. doi: 10.1042/BST0350405
27. Palmer AJ, Wallace HM (2010) The polyamine transport system as a target for anticancer drug development. Amino Acids 38(2):415-422. doi: 10.1007/s00726-009-0400-2
28. Pasini A, Caldarera CM, Giordano E (2013) Chromatin remodeling by polyamines and polyamine analogs. Amino Acids. doi: 10.1007/s00726-013-1550-9
29. Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48(4):759-774
30. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65(13):5506-5511. doi: 10.1158/0008-5472.CAN-05-0626
31. Ricardo S, Vieira AF, Gerhard R, Leitao D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J (2011) Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64(11):937-946. doi: 10.1136/jcp.2011.090456
32. Rosenberg B, Vancamp L, Krigas T (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698-699
33. Seiler N (2005) Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol Ther 107(1):99-119. doi: 10.1016/j.pharmthera.2005.02.001
34. Seiler N, Knodgen B (1985) Determination of polyamines and related-compounds by reversed-phase high-performance liquid-chromatography - improved separation systems. J Chromatogr 339(1):45-57
35. Silva TM, Oredsson S, Persson L, Woster P, Marques MP (2012) Novel Pt(II) and Pd(II) complexes with polyamine analogues: synthesis and vibrational analysis. J Inorg Biochem 108:1-7. doi: 10.1016/j.jinorgbio.2011.11.021
36. Silva T, Andersson S, Sukumaran S, Marques M, Persson L, Oredsson S (2013) Norspermidine and novel Pd(II) and Pt(II) polynuclear complexes of norspermidine as potential antineoplastic agents against breast cancer. PLoS One 8(2):e55651. doi: 10.1371/journal.pone.0055651
37. Soares AS, Fiuza SM, Gonçalves MJ, Batista de Carvalho LAE, Marques MPM, Urbano AM (2007) Effect of the metal center on the antitumor activity of the analogous dinuclear spermine chelates (PdCl2)2(spermine) and (PtCl2)2(spermine). Lett Drug Des Discov 4(7):460-463
38. Traquete R, Ghani RA, Phanstiel O, Wallace HM (2013) Ant 4,4, a polyamine-anthracene conjugate, induces cell death and recovery in human promyelogenous leukemia cells (HL-60). Amino Acids 44:1193-1203. doi: 10.1007/s00726-012-1452-2
39. Uimari A, Keinanen TA, Karppinen A, Woster P, Uimari P, Janne J, Alhonen L (2009) Spermine analogue-regulated expression of spermidine/spermine N1-acetyltransferase and its effects on depletion of intracellular polyamine pools in mouse fetal fibroblasts. Biochem J 422(1):101-109. doi: 10.1042/BJ20090411
40. Ulukaya E, Ari F, Dimas K, Ikitimur EI, Guney E, Yilmaz VT (2011) Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo. Eur J Med Chem 46(10):4957-4963. doi: 10.1016/j.ejmech.2011.07.055
41. Wallace HM, Fraser AV, Hughes A (2003) A perspective of polyamine metabolism. Biochem J 376(Pt 1):1-14. doi: 10.1042/BJ20031327
42. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4(4):307-320. doi: 10.1038/nrd1691
43. Wolff AC, Armstrong DK, Fetting JH, Carducci MK, Riley CD, Bender JF, Casero RA Jr, Davidson NE (2003) A Phase II study of the polyamine analog N1, N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin Cancer Res 9(16 Pt 1):5922-5928
44. Wu WJ, Zhang Y, Zeng ZL, Li XB, Hu KS, Luo HY, Yang J, Huang P, Xu RH (2013) Beta-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype. Biochem Pharmacol 85(4):486-496. doi: 10.1016/j.bcp.2012.11.017